Dyspepsia 3

Management of dyspepsia (The 2022

Indonesian Consensus Report )
• Patients with dyspepsia should undergo initial treatment with empirical proton pump
inhibitor (PPI) therapy with or without a prokinetic if there is no alarm symptom.

• After H. pylori eradication, FD patients with any dyspepsia

symptom should be treated with a PPI.
• Tricyclic antidepressants (TCAs) and prokinetics can be
considered as an optional therapy for patients with FD in whom
treatment with PPIs failed. An evaluation or re-evaluation of H.
pylori infection status should be conducted for such patients.
• Psychological therapies should be considered for FD patients with
no response prior to drug therapy.
Syam et al. Gut Pathogens (2023) 15:25 ; Management of dyspepsia and Helicobacter pylori infection:
the 2022 Indonesian Consensus Report
 The 2022 Indonesian Consensus Report

Syam et al. Gut Pathogens (2023) 15:25 ; Management of dyspepsia

and Helicobacter pylori infection: the 2022 Indonesian Consensus Report
The 2022 Indonesian Consensus Report

Syam et al. Gut Pathogens

(2023) 15:25 ; Management
of dyspepsia and Helicobacter
pylori infection: the 2022
Indonesian Consensus Report
 Algorithm of Managing Dyspepsia
at various level of health care units

( Vol 49 • Number 3 • July 2017 ,National consensus on management of dyspepsia and H. pylori infection )
 Algorithm of Managing
Functional Dyspepsia

( Vol 49 • Number 3 • July 2017 ,National consensus on management of dyspepsia and H. pylori infection )
Algorithm for the management of undiagnosed dyspepsia

Moayyedi et al. ACG and CAG Clinical Guideline 2017: Management of Dyspepsia
Algorithm for the treatment of functional dyspepsia

Moayyedi et al. ACG and CAG Clinical Guideline 2017: Management of Dyspepsia